Audible Logo
Audible, an Amazon company Help Sign In Audiobooks Podcasts Crime & Thrillers Sci-fi & Fantasy Fiction Health & Development Romance History More Categories Most popular New releases Coming soon Best of the year Audiobook series Plans & pricing
Limited Time Offer. Only AUD $0.99/mo for the first 3 months. Auto renews at $8.99 a month after 3 months. Cancel anytime. Get this deal.
Health & Wellness Physical Illness & Disease Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM

Episodes

  • Wrap Up

    Wrap Up

    Nov 19 2024
    2 mins

    Failed to add items

    Sorry, we are unable to add the item because your shopping cart is already at capacity.

    Add to basket failed.

    Please try again later

    Add to Wish List failed.

    Please try again later

    Remove from Wish List failed.

    Please try again later

    Follow podcast failed

    Unfollow podcast failed

    Listen for free
  • Long-Term Safety and Efficacy of Zilucoplan in Generalized Myasthenia Gravis 120-Week Interim Analysis of RAISE-XT

    Long-Term Safety and Efficacy of Zilucoplan in Generalized Myasthenia Gravis 120-Week Interim Analysis of RAISE-XT

    Nov 19 2024

    Author: Howard, JF, et al.
    Overview Provided by Nicolas Silvestri, MD

    Show More Show Less
    3 mins

    Failed to add items

    Sorry, we are unable to add the item because your shopping cart is already at capacity.

    Add to basket failed.

    Please try again later

    Add to Wish List failed.

    Please try again later

    Remove from Wish List failed.

    Please try again later

    Follow podcast failed

    Unfollow podcast failed

    Listen for free
  • Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 VIVACITY-MG3 Study

    Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 VIVACITY-MG3 Study

    Nov 19 2024

    Author: Strober J, et al.
    Overview Provided by Nicolas Silvestri, MD

    Show More Show Less
    3 mins

    Failed to add items

    Sorry, we are unable to add the item because your shopping cart is already at capacity.

    Add to basket failed.

    Please try again later

    Add to Wish List failed.

    Please try again later

    Remove from Wish List failed.

    Please try again later

    Follow podcast failed

    Unfollow podcast failed

    Listen for free
  • Concomitant Corticosteroid Use with Ravulizumab in Adults with Anti-Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: Phase 3 CHAMPION-MG Open-Label Extension Final Results

    Concomitant Corticosteroid Use with Ravulizumab in Adults with Anti-Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: Phase 3 CHAMPION-MG Open-Label Extension Final Results

    Nov 19 2024

    Author: Nicolle M, et al.
    Overview Provided by Nicolas Silvestri, MD

    Show More Show Less
    3 mins

    Failed to add items

    Sorry, we are unable to add the item because your shopping cart is already at capacity.

    Add to basket failed.

    Please try again later

    Add to Wish List failed.

    Please try again later

    Remove from Wish List failed.

    Please try again later

    Follow podcast failed

    Unfollow podcast failed

    Listen for free
© Copyright 2025 Audible Australia Pty Ltd Conditions of Use Privacy Notice Interest-Based Ads Cookies & Internet Advertising